ALINORM 03/26/1 - codex - BSN

REP12/CAC 19
107. Following some further debate and in the absence of consensus on whether the requirements of Rule
XII.2 had been met, the Chairperson proposed to vote on the following question: “Do you wish to proceed
with a vote on adoption of the proposed MRLs for ractopamine at this Session of the Commission?” (Vote 1).
The FAO Legal Counsel clarified that voting would be conducted either by a show of hands, a roll- call vote,
if requested by a Member, or a secret ballot, if so determined by the Commission.
108. A number of delegations wished that the vote be conducted by secret ballot. However, in the absence
of consensus on the manner of voting, the Commission carried out a vote by show of hands to decide on how
to conduct Vote 1.
109. It was noted that, as the European Union was competent to vote on this matter on behalf of its Member
States (see CRD1), the European Union cast 27 votes, one for each of the European Union Member States
present at the Session (at the start of the voting the presence of the 27 European Union Member States was
confirmed by the Secretariat). Prior to the vote, the Secretariat established that a quorum was present of more
than half of the members in attendance at the Session but not less than twenty percent of the membership of
Codex, or less than 25 members, as prescribed by Rule VI-7 of the Rules of Procedure.
Vote cast: 133
Majority required: 67
Votes in favour: 92
Votes against: 41
Abstaining: 3
Results: Vote 1 should be conducted by secret ballot.
110. In view of the above result, the Commission proceeded with Vote 1 by secret ballot. The presence of
the 27 European Union Member States was again verified by the Secretariat. Prior to the vote, the Secretariat
established that a quorum was present of more than half of the members in attendance at the Session but not
less than twenty percent of the membership of Codex, or less than 25 members, as prescribed by Rule VI-7
of the Rules of Procedure. The result of the secret ballot on Vote 1 was:
Ballots papers deposited: 136
Defective ballots: 0
Abstentions: 4
Votes cast: 132
Majority required: 67
Votes in favour: 68
Votes against: 64
Result: Proposal adopted; the Commission would proceed with a vote on the
adoption of the proposed MRLs for ractopamine at the present Session.
111. Following the results of Vote 1, the Commission proceeded with the vote on the following question:
“Do you wish to adopt the proposed MRLs for ractopamine?” (Vote 2).
112. The Commission agreed with the proposal of the Chairperson to proceed with Vote 2 by secret ballot.
The presence of the 27 European Union Member States was again verified by the Secretariat. Prior to the
vote, the Secretariat established that a quorum was present of more than half of the members in attendance at
the Session but not less than twenty percent of the membership of Codex, or less than 25 members, as
prescribed by Rule VI-7 of the Rules of Procedure.